Egrie J - Search Results

1

Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor.

Broudy VC, Smith FO, Lin N, Zsebo KM, Egrie J, Bernstein ID. Broudy VC, et al. Among authors: egrie j. Blood. 1992 Jul 1;80(1):60-7. Blood. 1992. PMID: 1377054 Free article.

2

Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide.

Broudy VC, Lin N, Egrie J, de Haën C, Weiss T, Papayannopoulou T, Adamson JW. Broudy VC, et al. Among authors: egrie j. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6513-7. doi: 10.1073/pnas.85.17.6513. Proc Natl Acad Sci U S A. 1988. PMID: 2842774 Free PMC article.

3

Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe human immunodeficiency virus infection.

Miles SA, Mitsuyasu RT, Lee K, Moreno J, Alton K, Egrie JC, Souza L, Glaspy JA. Miles SA, et al. Among authors: egrie jc. Blood. 1990 Jun 1;75(11):2137-42. Blood. 1990. PMID: 1693297 Free article.

4

The anemia of end-stage renal disease: hematopoietic progenitor cell response.

Segal GM, Eschbach JW, Egrie JC, Stueve T, Adamson JW. Segal GM, et al. Among authors: egrie jc. Kidney Int. 1988 May;33(5):983-8. doi: 10.1038/ki.1988.97. Kidney Int. 1988. PMID: 3392887 Free article.

5

A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects.

Eschbach JW, Haley NR, Egrie JC, Adamson JW. Eschbach JW, et al. Among authors: egrie jc. Kidney Int. 1992 Aug;42(2):407-16. doi: 10.1038/ki.1992.302. Kidney Int. 1992. PMID: 1405323 Free article. Clinical Trial.

6

Epitope mapping and immunoneutralization of recombinant human stem-cell factor.

Mendiaz EA, Chang DG, Boone TC, Grant JR, Wypych J, Aguero B, Egrie JC, Langley KE. Mendiaz EA, et al. Among authors: egrie jc. Eur J Biochem. 1996 Aug 1;239(3):842-9. doi: 10.1111/j.1432-1033.1996.0842u.x. Eur J Biochem. 1996. PMID: 8774734 Free article.

7

The safety of epoetin-alpha: results of clinical trials in the United States.

Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Eschbach JW, et al. Among authors: egrie jc. Contrib Nephrol. 1991;88:72-80. doi: 10.1159/000419517. Contrib Nephrol. 1991. PMID: 2040198 Clinical Trial. No abstract available.

8

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Eschbach JW, et al. Among authors: egrie jc. N Engl J Med. 1987 Jan 8;316(2):73-8. doi: 10.1056/NEJM198701083160203. N Engl J Med. 1987. PMID: 3537801 Clinical Trial.

9

USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients.

Eschbach JW, Downing MR, Egrie JC, Browne JK, Adamson JW. Eschbach JW, et al. Among authors: egrie jc. Contrib Nephrol. 1989;76:160-5; discussion 212-8. doi: 10.1159/000417892. Contrib Nephrol. 1989. PMID: 2684518 Clinical Trial. No abstract available.

10

The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.

Adamson W, Egrie JC, Browne JK, Downing MR, Eschbach W. Adamson W, et al. Among authors: egrie jc. Behring Inst Mitt. 1988 Aug;(83):188-92. Behring Inst Mitt. 1988. PMID: 3071336 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters